Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Gianluca Festini"'
Autor:
Antonino Neri, Manlio Ferrarini, Silvio Bicciato, Giorgio Lambertenghi Deliliers, Stefano Molica, Gianluca Festini, Vincenzo Callea, Mauro Spriano, Massimo Gentile, Francesco Ferrari, Serena Matis, Adrian Andronache, Giovanna Cutrona, Fortunato Morabito, Luca Agnelli, Katia Todoerti, Marta Lionetti, Sonia Fabris, Laura Mosca
Supplementary Figures S1-S2 and Supplementary Tables S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c837718f24adfda84663730bfe2cecf2
https://doi.org/10.1158/1078-0432.22442760.v1
https://doi.org/10.1158/1078-0432.22442760.v1
Autor:
Antonino Neri, Manlio Ferrarini, Silvio Bicciato, Giorgio Lambertenghi Deliliers, Stefano Molica, Gianluca Festini, Vincenzo Callea, Mauro Spriano, Massimo Gentile, Francesco Ferrari, Serena Matis, Adrian Andronache, Giovanna Cutrona, Fortunato Morabito, Luca Agnelli, Katia Todoerti, Marta Lionetti, Sonia Fabris, Laura Mosca
Purpose: Chromosome 13q14 deletion occurs in a substantial number of chronic lymphocytic leukemia (CLL) patients and it is believed to play a pathogenetic role. The exact mechanisms involved in this lesion have not yet been fully elucidated because o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::759d7ad24f343eaca959f0cdb78a50f4
https://doi.org/10.1158/1078-0432.c.6519429.v1
https://doi.org/10.1158/1078-0432.c.6519429.v1
Autor:
Anna Knezevich, Marina Busetti, Cristina Skert, Gianluca Festini, Marta Vidus, Roberto Luzzati, Jacopo Monticelli, Lucia Pelusi, Alfredo Perulli, Rossana Piani, Daniela Monteverdi, Cristina Lagatolla, Raffaela Bressan
Background: Multidrug-resistant (MDR) or extensively-drug-resistant (XDR) Pseudomonas aeruginosa (PSA) strains infections are a major concern in nosocomial environments being associated both with worse outcomes and with high mortality rates especiall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f81116afb9c5aa1de3164e2fe5e3b4aa
http://hdl.handle.net/11368/2927335
http://hdl.handle.net/11368/2927335
Autor:
Silvia Imbergamo, Rosanna Ciancia, Maria Grazia Michieli, Eros Di Bona, Manuela Caizzi, Maria Elena Zannier, Michele Gottardi, Filippo Gherlinzoni, Carla Filì, Jacopo Olivieri, Gianpietro Semenzato, Anna Ermacora, Gianpaolo Nadali, Maria Vittoria Dubbini, Anna Candoni, Davide Facchinelli, Renato Fanin, Davide Lazzarotto, Gianluca Festini
The hypomethylating agent Decitabine (DAC) is a valuable treatment option in acute myeloid leukemia (AML), particularly in elderly patients (pts) not suitable for intensive chemotherapy (CHT). However, limited data are available about efficacy and sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62a9ca635006ef3779f09b7dfbc62368
http://hdl.handle.net/11390/1143531
http://hdl.handle.net/11390/1143531
Publikováno v:
La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine. 12:252-255
Autor:
Giuseppe Longo, Luciano Levato, Caterina Musolino, Stefano Molica, Katia Todoerti, Simonetta Zupo, F. Di Raimondo, Giovanna Cutrona, Massimo Gentile, Serena Matis, Tait D. Shanafelt, N. Di Renzo, Isabel Alvarez, Sonia Fabris, Marina Ferrarini, Neil E. Kay, Giovanni Tripepi, Alessandra Recchia, Ugo Consoli, Annalisa Arcari, Francesco Angrilli, Fortunato Morabito, Agostino Cortelezzi, Massimo Federico, Ernesto Vigna, Iolanda Vincelli, Antonino Neri, Gianluca Festini, Donato Mannina, Francesca Romana Mauro
Publikováno v:
Leukemia. 30:1440-1443
A progression-risk score to predict treatment-free survival for early stage chronic lymphocytic leukemia patients
Autor:
Marta Medeot, Elisabetta Calistri, Massimiliano Bonifacio, Luca Frison, Gianpietro Semenzato, Mario Tiribelli, Federico De Marchi, Filippo Gherlinzoni, Cristina Bucelli, Luigi Scaffidi, Mauro Krampera, Elena Maino, Anna Guella, Rosaria Sancetta, Francesca Cibien, Gianluca Festini, Ercole De Biasi, Achille Ambrosetti, Nicola Orofino, Giovanni Pizzolo, Claudia Minotto, Renato Fanin, Gianni Binotto, Alessandra Iurlo, Manuela Stulle
Publikováno v:
Oncotarget
Second-generation tyrosine kinase inhibitors (2G-TKIs) dasatinib and nilotinib produced historical rates of about 50% complete cytogenetic response (CCyR) and about 40% major molecular response (MMR) in chronic myeloid leukaemia (CML) patients failin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7270c75970be5628c761b790926aa7e0
http://hdl.handle.net/11562/977811
http://hdl.handle.net/11562/977811
Autor:
Massimo Gentile, Massimo Federico, Caterina Musolino, Giovanna Cutrona, Katia Todoerti, Agostino Cortelezzi, Iolanda Vincelli, Marta Lionetti, Pellegrino Musto, Giuseppe Longo, Antonino Neri, Gianluca Festini, Francesca Romana Mauro, Manlio Ferrarini, Nicola Di Renzo, Francesco Di Raimondo, Serena Matis, Fiorella Ilariucci, Francesco Angrilli, Luciano Levato, Stefano Molica, Simona Zupo, Ugo Consoli, Fortunato Morabito, Sonia Fabris
Objective: We performed an external and multicentric validation of the predictive value of abdominal computed tomography (aCT) on time to first treatment (TTFT) in early stage chronic lymphocytic leukemia (CLL) patients. Methods: aCT was performed at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9d3fb1a74fc6efc6747b5c903bb11c1
http://hdl.handle.net/11570/3092898
http://hdl.handle.net/11570/3092898
Autor:
Filippo Gherlinzoni, Cristina Bucelli, Marta Medeot, Renato Fanin, Luca Frison, Massimiliano Bonifacio, Federico De Marchi, Achille Ambrosetti, Mauro Krampera, Claudia Minotto, Gianluca Festini, Mario Tiribelli, Elena Maino, Ercole De Biasi, Francesca Cibien, Alessandra Iurlo, Elisabetta Calistri, Anna Guella, Giovanni Pizzolo, Luigi Scaffidi, Gianpietro Semenzato, Gianni Binotto
Publikováno v:
Blood. 128:5434-5434
Background. Use of 2nd generation tyrosine kinase inhibitors (2G-TKIs) dasatinib (DAS) and nilotinib (NIL) in chronic phase (CP) chronic myeloid leukemia (CML) patients failing imatinib (IM) results in around 50% of sustained cytogenetic response, an
Autor:
G. Ciceri, Anna Grazia Recchia, Agostino Cortelezzi, Serena Matis, Marta Lionetti, Monica Colombo, Marco Gobbi, Iolanda Vincelli, Fortunato Morabito, Maura Brugiatelli, Massimo Federico, Caterina Musolino, Nicola Di Renzo, Sonia Fabris, Emanuela Anna Pesce, Laura Mosca, Gianluca Festini, Ugo Consoli, Luca Agnelli, Alberto Fragasso, Manlio Ferrarini, Francesco Di Raimondo, Stefano Molica, Massimo Gentile, Maria Grazia Lipari, Francesco Maura, Giovanna Cutrona, Marzia Barbieri, Fiorella Ilariucci, Antonino Neri, Francesco Angrilli, Francesca Romana Mauro
Recent studies have described chromosome 2p gain as a recurrent lesion in chronic lymphocytic leukemia (CLL). We investigated the 2p gain and its relationship with common prognostic biomarkers in a prospective series of 69 clinical monoclonal B-cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0fff36871fe51e78d33aeac5cd51fd4
http://hdl.handle.net/11573/486556
http://hdl.handle.net/11573/486556